Science in Boston

Broad Institute Machine Learning in Drug Discovery Symposium 2025
2025-11-07 08:30 - 18:00 (America/Vancouver) | Broad Institute, 415 Main Street, Cambridge, MA, 02142, United States
The fourth annual Machine Learning in Drug Discovery Symposium will highlight significant advancements in the application of machine learning techniques to drug discovery. The event will continue to bring together researchers applying machine learning to target validation, hit identification and optimization, clinical trial design, biologics, or other areas of drug discovery.
broad.io/mldd
This year, there will also be an in-person workshop on Bindcraft 11/6 from 12-4pm ET, the day before the symposium (lunch 12-12:30) followed by a tour of the Broad Institute museum space from 4-5pm. If you would like to attend this in-person only workshop, be sure to purchase a ticket that specifies “W/Workshop”.
The workshop will be hosted by Lennart Nickel, Doctoral Assistant in the Laboratory of Protein Design & Immunoengineering at EPFL. Abstract for the workshop: “Protein–protein interactions are central to biological function, making their design highly relevant for therapeutic and biotechnological applications. BindCraft is a user-friendly, open-source pipeline that enables high-accuracy binder hallucination based on AlphaFold2. In this workshop, participants will learn the theoretical foundations of binder design, how to identify binding sites and interaction hotspots, prepare input structures and configuration files, and run a standard BindCraft workflow. They will also gain insights into writing and customizing loss functions to guide design objectives, along with practical ideas for the experimental validation of designed binders.”
After an in-person ticket purchase, attendees will receive an email with a link to a poster abstract submission form. Note that there are 8 chances to win a $500 prize for a poster.
Graduate students who are selected to present posters at the symposium and are traveling to the symposium from outside the Boston area, may be eligible for travel assistance. If you meet these criteria, please send an email to mlinddsymposium@broadinstitute.org for information on applying.
For questions, contact mlinddsymposium@broadinstitute.org
Target audience: Academic researchers (students, trainees, and PIs), scientists working at non-profits, AI/ML developers, scientists from biotech and pharma

Transforming Healthcare and Life Sciences Using Generative AI on AWS
2025-11-13 12:30 - 17:00 | 101 Main Street, 101 Main Street Suite 900, Cambridge, MA, 02142, United States
About the event

Overview
The GenAI Catalyst team invites you to dive deep into managed AWS services for Generative AI and agent development, including Amazon Bedrock, Bedrock AgentCore, Amazon Q CLI and Kiro. You will gain hands on experience in building real world GenAI application, and learn about the Well-Architected principles for building production-grade Agentic AI solutions.
AI-powered research assistant can query against vast repositories of scientific literature, derive insights from multiomics healthcare data, and reason over regulatory policies to provide competitive intelligence analysis, and reduce bench-to-bedside time. Recent development in agentic AI and MCPs accelerate adoption of Generative AI in Healthcare and Life Science industry, by plugging in existing knowledge bases and boosting accuracy through customization.
Who will Attend
This event is for technology developers, solution architects, and business developers, or anyone who wants hands-on generative AI experience to solve customer challenges.
How to Attend
This in-person event, including Happy Hour, will take place at the AWS Boston office. Seats are limited, so please RSVP to secure your place.
This is a multi-customer event; therefore, we recommend reserving sensitive questions and conversations for a 1:1 meeting with your AWS account team.

2025 R&D Reimagined
2025-11-20 08:00 - 18:30 | MassBioHub, 700 Technology Square, Cambridge, MA, 02139, United States
Join MassBio for a dynamic, full-day event designed to connect MassBio members with the industry leaders transforming the life sciences with new technologies and services. This immersive experience will showcase how the right partnerships and platforms can supercharge R&D, streamline operations, and bring breakthrough therapies to patients faster.
At this event designed for biotech and pharma R&D leadership, you’ll gain practical knowledge and forge connections that can directly accelerate your science:
Participate in insightful panel conversations with experts shaping the future of the field
Learn about new technologies and trends during spotlight talks with market pioneers
Explore strategic collaborations in an exhibitor space featuring key partners
Network with other attendees during breakfast, lunch, and an end-of-day reception

2025 Annual Holiday Party Mixer
2025-12-03 17:00 - 20:00 | 100 Technology Square
Winter is in the air! And with cold weather and sweaters comes MassBio’s most anticipated mixer of the year – our 2025 Annual Holiday Party. Kick off the season with MassBio at a new location: 100 Technology Square – Atrium. This premier event gathers 700+ guests from MassBio’s member companies. Bring a colleague or make a few new friends while celebrating the holiday season.
This event is free for MassBio members; pre-registration is required.
View photos from our 2024 event.
Interested in increasing your company’s visibility in the #1 life sciences cluster in the world? Learn about sponsorship opportunities.
Engage with us on social media: Tag @MassBio on social media and use the hashtag #MassBioMembers for a chance to be featured on our social media channels. Don’t forget to follow us on LinkedIn, X, and Instagram to stay up-to-date.
As of December 1, 2023, MassBio will no longer allow walk-ins to attend our events. Please register early to ensure your spot! When alcohol is being served at MassBio events, we must limit participation to attendees over the legal drinking age of 21. To ensure compliance, IDs will be checked and guests under 21 or without ID will be turned away. We encourage younger members to take advantage of our other events, including premiere conferences and monthly forums.

MCB Community Forum
2025-12-05 16:00 - 17:00 | Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Cambridge, MA, 02138, United States
The MCB Community Forum takes place once each semester. This semester, MCB Chair Rachelle Gaudet will lead the meeting on Friday, December 5, at 4:00 pm in the BioLabs Lecture Hall, Room 1080.
The Community Forum is a great opportunity for the extended MCB community to discover what and who is new in MCB. During this Forum, recipients of the 2025 Doty-Losick Prize for Exceptional Service will be announced. (The nomination deadline has passed.)
The Forum – with a special TGIF will include pizza, beverages, and festive treats – will last about an hour, and there will be time for in-person questions.

Boston STEMPeers Meetup
2025-12-06 13:00 - 17:00 | Time Out Market Boston, 401 Park Dr, Boston, MA, 02215, United States
STEMPeers Boston Meet Up: Join us Dec 6, 2025 (1-5pm) at Time Out Market Boston for networking and talks by STEM leaders. All welcome!
Join STEMPeers for a special Boston Meet Up as we celebrate a decade of empowering STEM journeys! This engaging networking event will take place on December 6, 2025, from 1 PM to 5 PM at Time Out Market Boston, 401 Park Dr, Boston, MA 02215.
The session features four distinguished speakers bringing expertise from innovation, business development, immigration services, and entrepreneurship:
Arumugham (Ragoo) Raghunathan, Senior Director of Business Development at InSphero
Parthiban Rajasekaran, Innovation Lead at Sanofi
Melissa Scher, Director of Immigration Services, UMass Chan Medical School
Danika Khong, CEO and Co-Founder of Scismic
Network with professionals, learn from STEM leadership stories, and celebrate key milestones.

MGB Gene and Cell Therapy Institute Third Annual Symposium
2025-12-11 07:30 - 19:30 | 399 Revolution Drive, 399 Revolution Drive, Somerville, MA, 02145, United States
Join us for the MGB Gene and Cell Therapy Institute ‘s Third Annual Symposium from December11-12, 2025.

Save the date! Join us December 11–12, 2025 for the 3rd Annual Gene and Cell Therapy Research Symposium. This event is a continuation of our commitment to groundbreaking scientific discoveries in gene and cell therapy.Following the success of our inaugural symposium in 2023 and the continued momentum in 2024—which drew over 500 registrants and featured keynote speakers from top research institutions—we are thrilled to welcome an even more expansive audience this year.
Our 2025 keynotes include Carl June, PhD (University of Pennsylvania) and David Liu, PhD (Broad Institute), two of the most influential figures in the gene and cell therapy landscape.Immerse yourself in this dynamic two-day event filled with engaging talks by leading innovators and a poster session highlighting cutting-edge research in the field.

2025 Advancing Drug Development Forum
2025-12-11 08:00 - 17:00 | UMASS Club
This forum is designed to allow free-flowing dialogue and plenty of time has been woven throughout the day to assure interactive quality networking.
The forum strives to attract and stimulate dialogue with key opinion leaders in biotech and pharma, executive leadership, senior directors, consultants, and a close network of CROs and CDMOs to further explore together novel solutions, promising technology breakthroughs and hearing how the entrepreneurial industry leaders are introducing and incorporating novel approaches in small molecule drug development, changing timelines and ROIs. Hear for yourself, how you can speed up your timelines and improve your product quality.
The program will include two keynote presentations, the first presentation of the day is an interview with a biotech CEO that has seen their company change dramatically within the last year. The second keynote is from an Academic that is bringing future innovations to the industry. At the end of the day a fireside chat is moderated with two inspiring individuals from our industry.
Throughout the program there are several provocative and focused panel discussions and plenty of opportunity for inactive dialogue between faculty and attendees. It is imperative that everyone comes open-minded, ready to explore and share various approaches so that together we can find better ways to break down barriers and improve past standard methods for developing complex and challenging drug formulation and manufacturing methods.
Within our scope, we will learn better ways for biotech and pharma executives, consultants, CROs and CDMOs to learn to communicate, form strong relationships. and work seamlessly together. Discuss together how critical it is to invest one’s resources with the right partners to break down the barriers, and meet the demands and expectations to develop high quality.
Together, we will push each other to explore better ways to face new challenges that still lie ahead while searching for better solutions and begin to be more entrepreneurial, more efficient and incorporate technologies in development.

Boston International Symposium: Accelerating PSC-Derived Cell Therapies — Starting with the End in Mind
2025-12-11 09:00 - 2025-12-12 15:00 | Hyatt Regency Cambridge, 575 Memorial Drive, Cambridge, MA, 02139, United States
Program Description: Developing Pluripotent Stem Cell (PSC)-derived cell therapies presents exciting opportunities for novel and potentially curative approaches to intractable diseases, but also unique challenges that accompany a complex biological drug product. By working from the patient backwards, we can mitigate these challenges and optimize cell therapy development when each step is informed by the requirements of the final product. This unique program reverses the traditional “bench-to-bedside” approach by starting with the end goal – a successful and effective cell therapy – in mind when considering the entire development process. Connect with global leaders on the frontlines of developing ESC & iPSC-derived cell therapies as we bring together pioneers leading the most advanced clinical trials and innovators developing the next generation of technologies and platforms that will shape the future of the field.

Launch a Life Science Startup: Strategies for Success in Biotech & Beyond
2025-12-11 11:30 - 13:30 | Online
Learn the key strategies, funding insights, and expert advice to turn breakthrough science into a successful life science startup.

Turning breakthrough science into a successful company takes more than great research — it requires vision, strategy, and the right foundation for growth.
Join us for this insightful webinar as we explore the essential steps to launching and scaling a life science startup. Our panel of industry experts and entrepreneurs will share practical guidance on transforming innovative ideas into viable businesses. From navigating early-stage funding and intellectual property to building the right team and meeting regulatory milestones, you’ll gain actionable strategies to move from concept to commercialization.
Whether you are a researcher, aspiring founder, or biotech professional ready to take the next step, this session will equip you with the tools and insights to thrive in today’s dynamic life science landscape.
TOPICS:
How to validate and position your scientific innovation for market success
Building a solid business model and go-to-market strategy
Securing early-stage funding and engaging with investors
Navigating regulatory, IP, and partnership considerations
Lessons learned from successful biotech and life science founders

AGENDA:
Networking (11:30 am – 12 pm EST)
Presentation (12 pm – 1:15 pm EST)
OUR SPEAKERS:
Tomas Silicaro is an Argentine entrepreneur and the CEO & Co-Founder of Bioeutectics, a biotech company pioneering the next generation of natural, biodegradable, and high-performance solvents. Founded in 2020 in Argentina, Bioeutectics is now expanding globally, with operations in the U.S. and partnerships across Europe and Latin America.
Before founding Bioeutectics, Tomas spent more than 15 years leading market development and innovation initiatives across Latin America, gaining deep insight into how to translate scientific breakthroughs into scalable commercial solutions.
Under his leadership, Bioeutectics has attracted strategic investment — including from Syensqo Ventures (formerly Solvay Ventures) — and has been recognized by global organizations such as Hello Tomorrow, Falling Walls, and FoodTech for its impact in sustainable chemistry.
Tomas’ mission is to redefine industrial chemistry by replacing petrochemical solvents with nature-inspired, circular, and scalable alternatives, driving a cleaner, safer, and more resilient global food system. Read more at: https://www.linkedin.com/in/tomas-silicaro-85112922/
Matt Sillick is an innovative food materials scientist. He is CTO and co-founder of Paragon Pure, a company that creates wholegrain, readily soluble sprouted brown rice powders that enable sugar reduction and offer a clean-label alternative to maltodextrins. While with Paragon Pure, Matt has initiated a USDA grant project, established IP and led product development. Matt has contributed to patented innovations in a range of food science disciplines, including flavor delivery systems, solutions to enhance the dissolution rate of poorly soluble sweetness-modifying ingredients, technologies for granule and powder formation, and lipid oleogel systems. He previously worked for Ingredion, where he led the confocal and electron microscopy lab for characterizing food structures. Matt earned an MS in Materials Science at Georgia Tech, where he completed a thesis project on the synthesis and characterization of polycarbosilane as a precursor to silicon carbide fibers. Read more at: https://www.linkedin.com/in/matthew-sillick-97a51810/
John Zandbergen has over 20 years corporate experience within the life science, IVD and MedTech industry. He has worked internationally managing different sales organizations and leading different teams worldwide. This has led to building up an extensive network of companies and healthcare key opinion leaders. This is of great value to not only identify international market needs and requirements, but also in bringing new products to the market. His interest in Bioprinting and regenerative medicine was formed after consulting for a local 3D printing company which has designed and developed a basic bioprinter. Read more at: https://www.linkedin.com/in/john-zandbergen-304b6115/
EVENT MODERATOR:
David Postolski, Esq. is a senior partner at Gearhart Law, is a registered patent attorney and Intellectual Property (IP) attorney for close to 20 years. David specializes in assisting inventors, creators, artists, start-ups, entrepreneurs, early-stage companies, and emerging companies with their U.S and international IP strategy, protection, enforcement, and monetization. David is a frequent speaker and author on emerging IP issues and technologies including, raising capital, business formation, food science, software, licensing, Data and Privacy Compliance, equity-based crowdfunding, and compliance with other US and International Regulatory structures. David is also a Professor at Temple University, Parsons School of Design and the Radzyner Law School (Herzliya, Israel) where he teaches master-level students about IP, ethics, and other regulatory considerations. David is a current Council Member of the American Bar Association Section of Intellectual Property Law, founder of their International Action Group, and editor of their monthly newsletter, and the outgoing Continuing Legal Education (CLE) Officer. David currently serves on Harvard’s Lemann Entrepreneurial Program Advisory Board. Read more at: https://gearhartlaw.com/
Email David D. Postolski, Esq.. with any questions at david@gearhartlaw.com

The Dish with Johannes ft. Phillip Sharp: LIVESTREAM
2025-12-11 15:00 - 16:30 | Online
LabCentral is honored and excited to host a livestream of our founder-based video series, The Dish! Join us for a very special episode featuring Biogen co-founder, MIT Institute Professor, and Nobel prize winner, Phillip Sharp.
Phillip Sharp is an Institute Professor at MIT and a renowned geneticist and molecular biologist whose discoveries transformed the world’s understanding of gene expression. As co-founder of Biogen and Alnylam Pharmaceuticals, Sharp’s contributions have been instrumental in building Cambridge’s biotech ecosystem. Awarded the 1993 Nobel Prize in Physiology or Medicine for his discovery of RNA splicing, Dr. Sharp has been a driving force in bridging fundamental research and biotechnology innovation.
The program is expected to run approximately 45 minutes, with additional time at the end for questions from attendees.
Space is limited to 500 virtual attendees, so please RSVP for your opportunity to join us live in the audience. Be sure to submit your questions for Phil ahead of time during registration! Are you ready to Dish?

Better Together
2025-12-11 16:30 - 20:00 | Ragon Institute, 600 Main St., Cambridge, MA, 02139, United States
International development and scientific inquiry are facing a historically difficult moment with an uncertain future. How do we go from here to a world where everyone benefits from biomedical research?
This panel brings together experts from academia, industry, and government to explore this moment and chart a path forward. Our speakers will discuss the current landscape, share different perspectives on international scientific cooperation, and tackle a fundamental question: how do we build a world where everyone benefits from the transformative power of science? And how do we remove barriers to participation?

After Dark Series
2025-12-11 18:00 - 21:00 | MIT Museum, 314 Main Street, Cambridge, MA, 02142, United States
Enjoy a lively evening of entertainment, science, and tinkering for the 18+ crowd!

After Dark is a monthly adults-only, after-hours event at the museum. Full of science and surprises, expect demonstrations, tastings, conversation and interactive play. Our galleries will be open for you, and we’ll always have live music, cash bar, and bites for purchase by culinary specialists from around the city.
6pm–9:00pm
18+ only
Admission:
Advanced General Admission: $20 (Non-Refundable)
Day-Of General Admission: $25
MIT ID Holders: $10
Space is limited. Pre-registration strongly suggested.

Worming Our Way Through Time: How Animals Sense Time Within and Across Generations
2025-12-13 15:00 - 16:00 | MIT Museum, 314 Main Street, Cambridge, MA, 02142, United States
How do animals perceive time — both in the moment and across generations?

Research with the tiny worm C. elegans is offering surprising insights. With every brain cell and connection mapped, and many genes and molecules shared with humans, these transparent worms are a powerful tool for understanding how living beings sense and respond to time.
MIT postdoctoral researcher Eugene Lee will share how training worms to remember specific timing patterns not only shapes their own behavior, but also sends signals that influence the health and behavior of their offspring.
The talk will include live specimens of C. elegans, allowing audiences to see firsthand how much can be learned by simply observing these remarkable creatures under a microscope.
This program is free with Museum admission. While walk-ins are welcome, advance registration is recommended to reserve your spot.
December 13
3pm – 4pm
Free with Museum admission.

The Biology of Time: From Embryos to Aging Cells
2026-01-21 18:00 - 20:00 | MIT Museum, 314 Main Street, Cambridge, MA, 02142, United States
Leading biologists Ruth Lehmann and Siniša Hrvatin share their groundbreaking research on how living systems persevere, pause, and adapt across generations.

Lehmann’s lab investigates germ cells—the remarkable cells that make eggs and sperm, carry our genetic material forward, and resist the ravages of time. Their study reveals how these cells migrate, transform, and even evade aging and disease.
Hrvatin’s lab explores how animals slow the effects of time through daily torpor and hibernation. By studying how these natural suspended states protect against tissue damage, disease, and aging, the team hopes to uncover insights that could one day help us influence the aging process itself.
Following their short presentations, Antonio Regalado, senior editor for biomedicine at MIT Technology Review, will moderate a lively discussion and audience Q&A on what these discoveries mean for the future of human health.
A reception will follow the event.
January 21
6pm – 8pm
$15 General Admission, $5 for MIT ID Holders

Chemical Advances in Biomaterials and Therapeutics (CABT)
2026-01-22 09:00 - 19:00 | Northeastern University, 360 Huntington Avenue, 105 Shillman Hall, Boston, MA, 02115, United States
CABT features talks, posters, and networking to connect industry and academia on biomaterials, drug delivery, tissue engineering and more!

Attendees will have the opportunity to engage in technical talks, poster session, and networking. The event is also aimed at fostering meaningful dialogue between industry and academia. For posters, we invite submissions from researchers in Greater Boston working on areas including but not limited to synthesis, characterization of lipids, polymers/nanomaterials for drug or gene delivery, stimuli-responsive biomaterials, immunomodulatory biomaterials, medical devices, and materials for tissue engineering, regenerative medicine.
Confirmed Speakers:
Rigoberto Hernandez (President, ACS), Johns Hopkins University
Abraham Joy, Northeastern University
Alan Enciso, GlaxoSmithKline
Eric Dane, AstraZeneca
Gulden Camci-Unal, UMass Lowell
Mark Grinstaff, Boston University
Matthew Becker, Adaptilens/Duke University
Thomas Jozefiak, Glycologix
All academic (undergraduates, graduates, post-docs, professors), industry, government researchers are welcome to submit their work as a poster. The submission will close on Jan. 7, 2026. Please click on the link below to provide all required information.

Ending HIV: The Journey to a Vaccine
2026-02-19 19:00 - 21:00 | Museum of Science, 1 Science Park, Boston, MA, 02114, United States
Set over 25 years, scientists, doctors, and volunteers pursue an HIV vaccine, confronting scientific setbacks and breakthroughs along the way. As communities around the world rally to support the effort, Ending HIV: The Journey to a Vaccine captures the global collaboration, personal sacrifices, and enduring commitment driving one of medicine’s most urgent and ambitious quests.
Don’t miss this timely, award-winning documentary followed by an in-person discussion with the film team and featured scientists Dr. Anthony Fauci and Dr. Larry Corey, only at the Museum of Science!
The Raw Science Film Festival is a pioneering global platform dedicated to humanizing science and keeping fact-based expertise at the forefront of popular culture. Founded in 2014 and now based in New York, the festival celebrates the world’s best science and technology storytelling across documentary, narrative, and animated films. Its mission is to elevate scientific voices and ideas through powerful, accessible media—creating a red-carpet, Oscars-style experience that spotlights filmmakers, scientists, technologists, and the stories shaping our future. With ambitions to become an Oscar-qualifying festival, RSFF is committed to ensuring that rigorous, inspiring science storytelling reaches the widest and most influential audiences worldwide.
Each ticket includes a signed copy of On Call: A Doctor’s Journey in Public Service by Dr. Fauci. Screening and conversation followed by reception.

Better Together: A Pharma & Biotech EHS Forum
2026-02-25 08:30 - 15:00 | Museum of Science, 1 Science Park, Boston, MA, 02114, United States
Reimagine what’s possible in pharma—together.
The pharmaceutical (or pharma) industry is evolving faster than ever and stands at the crossroads of science, innovation, and regulatory excellence.
BSI Consulting’s “Better Together: A Pharma & Biotech EHS Forum” brings pharma and biotech professionals and EHS thought leaders together to ask the hard questions and share practical insights for navigating the industry’s next era.
Event information:

Date and time: February 25, 2026 | 8:30 am – 3:00 pm EST
Location: Museum of Science

1 Science Park, Boston, MA 02114
Free parking will be available on-site

Eat and connect: Lunch and drinks will be served during the event.

During this one-day event, you’ll be part of conversations that matter:

Keynote spotlight: Hear from an AI expert on the dynamic opportunities and limitations of AI use in pharma.
Multi-track sessions: Tailored tracks with guest speakers from globally recognized pharma companies bringing expertise on biosafety, unseen risks of waste misclassification, and how to bridge competency gaps.
Interactive discussions: Collaborate in facilitated groups to understand and identify shared industry challenges to co-create actionable solutions.

You’ll walk away with a new network of relationships, see the value of cross-collaboration, and feel a renewed sense of purpose in your work.
View the full agenda!
Who should attend?

Pharma executives and professionals
Biotech executives and professionals
EHS directors, managers, and specialists

If you’d like to reserve your spot and receive updates related to the event, please fill out the form before February 24, 2026.

11th Annual Rare Disease Day Event
2026-02-25 13:30 - 17:00 | Broad Institute, 415 Main Street, Cambridge, MA, 02142, United States
Rare Disease Day is an international event held in late February to raise awareness about the impact on patients and need for research.

The event will take place on Tuesday, February 25, 2026 from 1:30 – 5:00pm ET in the Merkin Building at the Broad Institute of MIT and Harvard (415 Main Street, Cambridge, MA 02142) and streamed online. Registration will begin at 1:00pm, the speaking program will be held from 1:30 – 5:00pm in the Merkin Auditorium, and a reception will follow from 5:00 – 6:00pm in the Broad Discovery Center.
This year, the Broad Institute’s Ladders to Cures Scientific Accelerator in collaboration with The Termeer Institute are hosting the 11th Annual Rare Disease Day Event, featuring opening remarks from Anna Greka and Belinda Termeer, and a lineup of speakers from the rare disease space including Mandana Arbab, Hilary Eaton, Kasper Roet, Juliana Gentile, Dan Leonard, and Allyson Berent.
Rare genetic diseases are collectively common: they affect 1 in 10 people in North America. While more than 8,000 genes are known to drive these diseases, fewer than 500 have an available treatment. The mismatch in these numbers underscores the urgent need to disrupt the status quo and develop new approaches to deliver precision cures at scale.
The Ladders to Cures Scientific Accelerator is committed to uncovering the genetic roots of rare diseases and to using those insights to develop new treatments. With projects spanning multiple disease areas, Broad scientists are using genetics, functional genomics, computational biology, and chemical biology to better understand and ultimately seek effective treatments for rare diseases.
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Institute is a nonprofit organization working to connect the world of healthcare innovators until every patient has a cure.
If you have any questions regarding the event or an accessibility request, please reach out to Katie Liguori at kliguori@broadinstitute.org.

The Collective Cure: Upstream Solutions for Better Public Health
2026-02-26 19:00 - 21:00 | Museum of Science, 1 Science Park, Boston, MA, 02114, United States
Join the Museum of Science for a compelling conversation with Dr. Monica Wang, award-winning public health researcher, and educator celebrating the release of her new book, The Collective Cure (Beacon Press), exploring how the spaces where we live, work, learn, and connect shape our health long before we enter a clinic.
Drawing from the powerful, story-driven narrative at the heart of her book, Dr. Wang illuminates the social and structural forces that influence well-being, from income and neighborhood conditions to social connection and belonging. Through the lived experiences of three extraordinary women across the United States, and through her own journey growing up as an Asian American bussing student and working mother, she reveals how upstream factors create downstream health outcomes- and what we can do about it.
In conversation with Indira Lakshmanan, award-winning journalist and editorial leader, Dr. Wang will go beyond the pages of The Collective Cure (Beacon Press) to discuss actionable, community-centered strategies for building healthier futures. With clarity, urgency, and optimism, she will invite us to reimagine what becomes possible when we shift our focus from individual fixes to collective solutions.
This conversation is for anyone interested in what helps individuals and communities thrive, build resilience, and navigate the systems that shape our lives. Discover how evidence-based, upstream approaches can transform public health- and how each of us can play a part in creating healthier communities from the ground up.
Followed by book signing. Copies of The Collective Cure (Beacon Press) for sale on-site.

SpaceTime TeaTime
2026-02-28 13:00 - 14:30 | MIT Museum, 314 Main Street, Cambridge, MA, 02142, United States
Explore the weird and wonderful qualities of time travel and black hole physics with MIT physics professor Scott Hughes and his students.

Using movies and TV shows as the serving platter, you’ll nosh upon different facets of astrophysical relativity and chat about their intersection with history, technology, pop culture, and the universe as we know it today.
This special afternoon “relativi-tea” includes a delicious traditional afternoon tea, offering a selection of teas, pastries, and finger sandwiches to enjoy while you ponder the conundrums of time and space around a black hole. Food for thought has never been so tasty!
If you have dietary restrictions, please email kswilson@mit.edu
February 28
1pm – 2:30pm
$15 General Admission, $5 for MIT ID Holders

OPT Congress 2026
2026-03-18 08:00 - 2026-03-19 17:00 | Seaport Hotel Boston, 1 Seaport Lane, Boston, MA, 02110, United States
OPT Congress 2026 is the leading industry event for scientists, directors, and technology providers driving innovation across oligonucleotide, mRNA, and peptide therapeutics. Now in its 11th year, this event provides a unique forum for translating cutting-edge science into transformative medicines, with expanded 2026 programming that includes the brand-new Peptides & Emerging Drug Conjugates conference. This year’s agenda brings together experts from discovery through development, with dedicated content spanning AI-enabled design, extrahepatic delivery, scalable manufacturing, and next-gen modalities including saRNA, circular RNA, and radioligand peptide conjugates.
Across four focused conferences —Oligonucleotide Discovery & Delivery, CMC & Manufacturing, mRNA & Emerging Modalities, and Peptides & Emerging Conjugates—attendees will explore 60+ scientific presentations, collaborative case studies, and real-world implementation strategies. From novel linkers and chemistries to regulatory insights, tech transfer, and delivery breakthroughs, OPT Congress fosters dialogue between pharma, biotech, academia, and technology providers. Join us for two days of actionable insights, short courses, and customizable content designed to support your therapeutic programs from bench to bedside.

Cell & Gene Therapy Summit
2026-03-26 08:00 - 17:00 | Marriott Boston Cambridge, 50 Broadway, Cambridge, MA, 02142, United States
Connect with Fellow Leaders Shaping Cell and Gene Therapy Development
The eighth in a series of premier one-day events held in the world’s biggest biotech hubs, Charles River is bringing together the leading experts, executives, and thought leaders in the CGT space to discuss and navigate critical challenges.
Register today to save your seat for an exclusive event aimed to inspire, educate, and connect you with the people shaping the future of advanced therapies.

MassBio State of Possible Conference
2026-03-26 08:00 - 17:00 | Omni Hotel Boston at the Seaport, 450 Summer St, Boston, MA, 02210, United States
Massachusetts IS the state of possible and you can see it personified at the premier event of the year for the Massachusetts life sciences industry – MassBio’s 2026 State of Possible Conference at the Omni Boston Seaport.
Every scientific breakthrough begins long before the headlines. It starts in the unseen moments on lab benches and in boardrooms. This year’s State of Possible Conference reveals the stories behind the breakthroughs, spotlighting the people, passion, and purpose that fuel innovation. You’re invited to explore collaboration and creativity, learn about leadership and motivation, and celebrate the power of science to change patient lives.
Join executives, scientists, innovators, and policymakers in March at the event that unites this community in our shared mission. You can expect an agenda featuring prominent leaders from pharma and biotech speaking on timely topics, along with the rewarding interactions you’ve come to expect.
Be in the room for Massachusetts’s premier conference for the life sciences, featuring remarks from Governor Maura Healey, insightful panel discussion with biotech leaders, and lots of networking. This is the not-to-be-missed event of the year where industry leaders convene – secure your spot today!

23rd Annual Strategic Alliance Management Congress
2026-03-31 08:00 - 2026-04-01 17:00 | Aloft Boston Seaport District
As biopharmaceutical innovation becomes more collaborative and global, effective alliance management increasingly plays a decisive, business-critical role—transforming partnerships into powerful engines of progress. Now in its 23rd year – CHI’s Strategic Alliance Management Congress is the leading forum for alliance professionals to gain strategic insights, benchmark with peers, and explore emerging tools and models shaping the future of partnering. Join us to strengthen your capabilities, expand your network, and maximize the value of every collaboration.

2026 Annual Microbiome Symposium
2026-04-17 09:00 - 17:00 | Schwarzman College of Computing, Building 45, 51 Vassar Street, Cambridge, MA, 02139-4307, United States
The MIT Center for Microbiome Informatics and Therapeutics and the MIT Microbiome Club are proud to invite you to attend our annual MIT Microbiome Symposium on Friday, April 17th, 2026 from 9:00am –5:00pm at MIT Building 45 (Schwarzman College of Computing).
Registration is now open for both in-person and virtual attendance!
The symposium will feature talks from established and young investigators, poster sessions, expert Q&A sessions, industry tables, and a networking social to close the day. This year, we are proud to host Dr. Andrew Goodman (Yale University) and Dr. Sean Brady (Rockefeller University) as our two keynote speakers.
To participate in the event:

Register for free on our Eventbrite page.
Submit an abstract! Abstracts can be considered for either a flash talk or a poster. Posters will also participate in our annual poster competition. Submissions are due March 6th.
Please tell others about this event! Feel free to share this page and the registration links with others who might be interested.

For those planning to attend in person, we kindly ask registered participants to consider our limited space. If you are unable to join in person for any reason, please cancel your registration. Your cooperation is highly appreciated.
Please contact microbiome-exec@mit.edu with any questions or inquiries.
Your participation in this symposium is free. Our goal is to showcase the diverse opportunities available in the field of microbiome science, and we hope that you can join us!
We look forward to seeing you in April!
Best regards,
2026 Microbiome Symposium Organizing Team

NOVA 2026
2026-04-25 08:00 - 17:00
NOVA is a conference catalyzing innovation in brain aging in Boston, organized by the Aging Initiative and bringing together the brightest minds from the entire stakeholder spectrum to advance this essential area of neuroscience. From biotechnology executives to investors, trainees to seasoned academics, patient care advocates, policymakers, and more, this gathering comes at a major inflection point in our understanding and treatment of age-related neurological conditions. With millions of patients, caregivers, and providers facing neurodegenerative diseases, age-related decline, and injury every day, we believe innovative cross-disciplinary solutions are essential. Especially now, it is of the utmost importance that we galvanize collaboration and inspire the next generation to take action. Through NOVA, we will change how the field of neuroscience thinks about brain aging, its manifestations, and ultimately, how to advance the race towards cures.

Digital Healthcare Innovation Summit (DHIS)
2026-04-27 08:00 - 2026-04-28 17:00 | Seaport Hotel Boston, 1 Seaport Lane, Boston, MA, 02110, United States
Join leading healthcare innovators and investors at the Digital Healthcare Innovation Summit (DHIS) in Boston, MA. We’ll examine timely topics, such as direct-to-consumer healthcare, underserved populations, important regulatory or policy changes, distributed vs. centralized care, women’s health, IaaS and IoT in healthcare, and more. Catch lively panels, take part in interactive breakouts, and network with industry leaders in this tight community. Investors, start-ups & emerging companies, tech companies, payers, providers, and veteran advisors will all be attending, so don’t miss out. This premier boutique digital health event helps fuel healthcare innovation – be a part of it!

USAIC’s 20th Annual BioPharma Summit
2026-04-30 08:00 - 17:00 | The Newbury Boston Hotel, 1 Newbury St, Boston, MA, 02116, United States
USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

AI and the Future of Cancer Treatments
2026-05-28 19:00 - 21:00 | Museum of Science, 1 Science Park, Boston, MA, 02114, United States
Sophia Shalhout, PhD, is an Assistant Professor of Otolaryngology – Head and Neck Surgery at Harvard Medical School and a Principal Investigator at the Mike Toth Cancer Research Center at Mass Eye and Ear. Her groundbreaking research applies AI and big data analytics to complex biomedical data, with the goal of advancing personalized medicine for high-risk cancer patients.
Dr. Shalhout’s work goes beyond improving individual treatment plans- she is also using AI to accelerate the discovery of new therapies that target some of the most challenging, traditionally “undruggable” cancer proteins. By optimizing molecular interactions and drug-like properties, her approach merges computational biology with lab-based validation, opening doors to entirely new treatment options for deadly cancers.
Through presentation and conversation, Dr. Shalhout will share how these powerful technologies are reshaping the landscape of cancer care- from precision medicine to faster, smarter drug development.
Don’t miss this opportunity to hear firsthand from one of the leading minds at the intersection of AI and oncology- where innovation meets impact.
